Walgreens Boots Alliance Inc (NASDAQ:WBA) Holdings Cut by Natixis
Natixis reduced its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 45.0% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 225,757 shares of the pharmacy operator’s stock after selling 184,739 shares during the period. Natixis’ holdings in Walgreens Boots Alliance were worth $12,342,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Nelson Roberts Investment Advisors LLC bought a new position in shares of Walgreens Boots Alliance in the first quarter worth $25,000. Meridian Wealth Management LLC bought a new position in Walgreens Boots Alliance in the 1st quarter valued at about $25,000. Weaver Consulting Group bought a new position in Walgreens Boots Alliance in the 1st quarter valued at about $27,000. Sageworth Trust Co acquired a new position in Walgreens Boots Alliance during the 2nd quarter valued at about $27,000. Finally, Trustcore Financial Services LLC acquired a new position in Walgreens Boots Alliance during the 1st quarter valued at about $31,000. Institutional investors own 59.80% of the company’s stock.
Walgreens Boots Alliance stock traded up $0.60 during mid-day trading on Wednesday, hitting $57.48. The company’s stock had a trading volume of 2,038,903 shares, compared to its average volume of 4,385,283. Walgreens Boots Alliance Inc has a 52-week low of $49.03 and a 52-week high of $86.31. The company has a market cap of $50.21 billion, a PE ratio of 9.55, a price-to-earnings-growth ratio of 1.39 and a beta of 0.88. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. The firm’s 50 day moving average is $52.26 and its 200 day moving average is $55.21.
The company also recently declared a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Tuesday, August 20th will be issued a dividend of $0.458 per share. This represents a $1.83 annualized dividend and a dividend yield of 3.19%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Monday, August 19th. Walgreens Boots Alliance’s payout ratio is currently 30.40%.
Several brokerages have recently issued reports on WBA. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Wednesday. Bank of America dropped their price objective on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating on the stock in a research note on Monday, June 3rd. JPMorgan Chase & Co. cut their price objective on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating for the company in a report on Friday, June 28th. ValuEngine raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, June 28th. Finally, Morgan Stanley lowered their target price on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a report on Friday, August 23rd. Six analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $63.65.
In related news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total value of $10,869,505.04. Following the transaction, the chief accounting officer now owns 357,851 shares in the company, valued at $18,064,318.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 15.73% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: Short Selling – Explanation For Shorting Stocks
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.